Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells
{{output}}
Serine arginine-rich splicing factor 1 (SRSF1) is a key oncogenic splicing factor in various cancers, promoting abnormal gene expression through post-translational regulation. Although the protumoral function of SRSF1 is well-established, the effects of inhibi... ...
